NG CAROLYN 4/A
4/A · BICYCLE THERAPEUTICS plc · Filed May 31, 2019
Insider Transaction Report
Form 4/AAmended
NG CAROLYN
Director
Transactions
- Exercise of In-Money
Ordinary Shares
2019-05-28+141,668→ 1,207,410 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD) - Conversion
Ordinary Shares
2019-05-28+206,767→ 1,427,151 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD) - Conversion
Series B1 Preferred Shares
2019-05-28−1,272,733→ 0 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD)→ Ordinary Shares (1,272,733 underlying) - Exercise of In-Money
Series B1 Preferred Shares Warrants
2019-05-28−141,668→ 0 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD)→ Ordinary Shares (141,668 underlying) - Conversion
Series B2 Preferred Shares
2019-05-28−206,767→ 0 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD)→ Ordinary Shares (206,767 underlying) - Conversion
Ordinary Shares
2019-05-28+1,272,733→ 1,081,823 total(indirect: By Vertex Global Healthcare Fund I PTE. LTD)
Footnotes (2)
- [F1]Each Series B1 Preferred Share and Series B2 Preferred Share automatically converted into Ordinary Shares on a one for 1.429 basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
- [F2]Upon conversion of all of the Series B1 Preferred Shares into Ordinary Shares in connection with the Issuer's initial public offering, the Warrants became exercisable for Ordinary Shares. The Warrants had an exercise price of a nominal value per share and were exercised immediately prior to completion of the Issuer's initial public offering.